IRON +38.9%IRON +38.9%. Disc Medicine shares jumped after the company announced its bitopertin drug hit all primary and secondary endpoints in the pivotal Phase 3 APOLLO trial for a rare sun-sensitivity blood disorder.
NWCL −19.2%NWCL −19.2% on a day with no market, sector, or industry move to match and no peer stocks moving the same way. No company news in our sources explains this sharp, isolated drop.
TICKEREPS ESTEPS ACTSURPiEPS SURPRISEActual EPS against the consensus estimate, in percent.LAST QiLAST Q REACTIONThe labelled reaction window around the previous earnings event: a verified announcement session or a release-date window when the announcement time is unknown. Open the row for the last eight quarters.
SURPiEPS SURPRISEActual EPS against the consensus estimate, in percent.—
LAST QiLAST Q REACTIONThe labelled reaction window around the previous earnings event: a verified announcement session or a release-date window when the announcement time is unknown. Open the row for the last eight quarters.—
SURPiEPS SURPRISEActual EPS against the consensus estimate, in percent.—
LAST QiLAST Q REACTIONThe labelled reaction window around the previous earnings event: a verified announcement session or a release-date window when the announcement time is unknown. Open the row for the last eight quarters.—
SURPiEPS SURPRISEActual EPS against the consensus estimate, in percent.—
LAST QiLAST Q REACTIONThe labelled reaction window around the previous earnings event: a verified announcement session or a release-date window when the announcement time is unknown. Open the row for the last eight quarters.—
partialTwelve Data via Himma· 3 earnings in the reported and upcoming windows
Provider calendar coverage is partial; known events remain visible.
Sector pulseiSECTOR PULSEHow each of the 11 market sectors is moving today, based on the largest US companies in it. Bigger companies count for more. Click a sector to see which stocks are leading and lagging.
